Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR012954)
Formula Reactant Ibrutinib Product PCI-45773 (M35)
Reactant Info Product Info
Metabolic Type Oxidation - Hydrolyzationn
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012962 Ibrutinib Desacryl-Ibrutinib Unclear Ibrutinib [1]
MR012963 Ibrutinib PCI-45227 (M37) Multi-steps Reaction - Epoxidation; hydrolyzation Ibrutinib [2]
MR012956 Ibrutinib PCI-45741 (M25) Multi-steps Reaction - Dehydrogenation; hydroxylation; reduction; oxidation Ibrutinib [2]
MR012958 Ibrutinib PCI-45752 (M34) Unclear Ibrutinib [2]
MR012946 Ibrutinib PCI-48303 (M26) Conjugation - Glutathione conjugation Ibrutinib [2]
MR012961 Ibrutinib PCI-7503 (M23) Hydrolysis - Hydrolyzation Ibrutinib [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012955 PCI-45773 (M35) Ibrutinib Metabolite M17 Reduction - Reduction Ibrutinib [3]
References
1 Extrahepatic metabolism of ibrutinib
2 Absorption, metabolism, and excretion of oral 14C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men. Drug Metab Dispos. 2015 Feb;43(2):289-97.
3 DrugBank(Pharmacology-Metabolism):Ibrutinib

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.